Get started
Author

Tomohiro Funakoshi

Risk of Metabolic Complications in Kidney Transplantation After Conversion to mTOR Inhibitor: A Systematic Review and Meta-Analysis
2014 · N. Murakami, L.V. Riella, et al. · American Journal of Transplantation · 113
Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial
2013 · K. Iseki, H. Arima, et al. · Nephrology Dialysis Transplantation · 99
A systematic review of predictive and prognostic biomarkers for VEGF-targeted therapy in renal cell carcinoma
2013 · Tomohiro Funakoshi, Chung-Han Lee, et al. · Cancer Treatment Reviews · 80
Risk of hypertension in cancer patients treated with sorafenib: an updated systematic review and meta-analysis
2013 · T Funakoshi, A Latif, et al. · Journal of Human Hypertension · 54
Safety and efficacy of addition of VEGFR and EGFR-family oral small-molecule tyrosine kinase inhibitors to cytotoxic chemotherapy in solid cancers: A systematic review and meta-analysis of randomized controlled trials
2014 · Tomohiro Funakoshi, Asma Latif, et al. · Cancer Treatment Reviews · 36
Risk of hypothyroidism in patients with cancer treated with sunitinib: A systematic review and meta-analysis
2013 · Tomohiro Funakoshi, Yuichi J. Shimada · Acta Oncologica · 35
PDF
Risk of hematologic toxicities in cancer patients treated with sunitinib: A systematic review and meta-analysis
2013 · Tomohiro Funakoshi, Asma Latif, et al. · Cancer Treatment Reviews · 34
Infectious complications in cancer patients treated with anti-EGFR monoclonal antibodies cetuximab and panitumumab: A systematic review and meta-analysis
2014 · Tomohiro Funakoshi, Maya Suzuki, et al. · Cancer Treatment Reviews · 30
Infection risk in breast cancer patients treated with trastuzumab: a systematic review and meta-analysis
2014 · Tomohiro Funakoshi, Maya Suzuki, et al. · Breast Cancer Research and Treatment · 17
Risk of hematologic toxicities in patients with solid tumors treated with everolimus: A systematic review and meta-analysis
2013 · Tomohiro Funakoshi, Asma Latif, et al. · Critical Reviews in Oncology/Hematology · 17
Abstract A159: Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A meta-analysis of randomized controlled trials
2016 · Tomohiro Funakoshi, Hyman Muss, et al. · Cancer Immunology Research · 5
Impact of Prescription Patterns on Compliance With Follow-Up Visits at an Urban Teaching Primary Care Continuity Clinic
2014 · Atsushi Sorita, Tomohiro Funakoshi, et al. · Journal of Primary Care & Community Health · 2
A comparison of toxicity profiles between standard and lower dose capecitabine (CAP) in breast cancer (BC): a meta-analysis.
2015 · Tomohiro Funakoshi, Maya Suzuki, et al. · Journal of Clinical Oncology
Abstract P3-12-03: Risk of infectious complications in breast cancer patients treated with trastuzumab: A meta-analysis
2015 · Tomohiro Funakoshi, Maya Suzuki, et al. · Cancer Research
Risk of Metabolic Complications in Kidney Transplantation After Conversion From Calcineurin Inhibitor to mTOR Inhibitor: A Systematic Review and Meta-Analysis.
2014 · N. Murakami, T. Funakoshi, et al. · Transplantation
Safety and efficacy of addition of VEGFR and EGFR-family small-molecule tyrosine kinase inhibitors to cytotoxic chemotherapy in solid cancers: A meta-analysis.
2014 · Tomohiro Funakoshi, Asma Latif, et al. · Journal of Clinical Oncology
Meta-analysis of hematologic toxicities in patients with solid tumors treated with everolimus.
2013 · Tomohiro Funakoshi, Asma Latif, et al. · Journal of Clinical Oncology
Meta-analysis of hematologic toxicities in patients with cancer treated with sunitinib.
2013 · Tomohiro Funakoshi, Asma Latif, et al. · Journal of Clinical Oncology
Colon Adenocarcinoma Metastatic to the Distal Extremity
2012 · Tomohiro Funakoshi, Koppany Visnyei, et al. · Journal of Gastrointestinal Cancer
Works count: 19
Citation count: 522
H-index: 10
I10-index: 10
Year
Topic
Type